Prevention and treatment of influenza in immunocompromised patients

American Journal of Medicine

Volumn 102, Issue 3A, 1997, Pages 55-60

  Hayden, Frederick G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INACTIVATED VACCINE; INFLUENZA VACCINE; RIBAVIRIN; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VIRUS SHEDDING;

AEROSOLS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMANTADINE; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; DRUG RESISTANCE, MICROBIAL; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; INFLUENZA, HUMAN; INFUSIONS, INTRAVENOUS; ORGAN TRANSPLANTATION; ORTHOMYXOVIRIDAE; PRIMARY PREVENTION; RIBAVIRIN; RIMANTADINE;

EID: 0031008429     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(97)80013-7     Document Type: Article

References (2)

1. Sable CA, Hayden FG. Orthomyxoviral and paramyxoviral infections in transplant patients. Infect Dis Clin North America. 1995;9:987-1003.
2. Bowden RA. Other viruses after marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Cambridge, MA: Blackwell Scientific Publication, 1994:443-453.